Clinical Trials Sponsored by Verastem, Inc.
Total 35595 results
-
Verastem, Inc.RecruitingMetastatic Cancer | Pancreas Cancer | Neoplasms Pancreatic | KRAS Activating Mutation | Malignant Neoplasm of PancreasUnited States
-
Verastem, Inc.Terminated
-
Verastem, Inc.TerminatedPancreatic CancerUnited States
-
Verastem, Inc.CompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
Verastem, Inc.TerminatedRelapsed Malignant MesotheliomaUnited States, United Kingdom
-
Verastem, Inc.Completed
-
Verastem, Inc.TerminatedLymphoma | Metastatic Cancer | Non Hematologic CancersUnited States, United Kingdom
-
Verastem, Inc.TerminatedMalignant Pleural MesotheliomaUnited States
-
Verastem, Inc.CompletedNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, Germany, Italy
-
Verastem, Inc.TerminatedMetastatic Cancer | Non Hematologic CancersUnited States
-
Verastem, Inc.CompletedNon Hematologic CancersJapan
-
Verastem, Inc.WithdrawnRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
-
Verastem, Inc.CompletedCancerUnited States, Canada
-
Verastem, Inc.CompletedOvarian CancerUnited States
-
Verastem, Inc.TerminatedMalignant Pleural MesotheliomaUnited States, Belgium, United Kingdom, Sweden, Italy, Netherlands, France, Japan, Australia, Canada, New Zealand, Norway, Poland, South Africa, Spain
-
Verastem, Inc.CompletedProstatic Neoplasm | Pancreatic Neoplasm | Head and Neck NeoplasmUnited States, Australia, Canada
-
Verastem, Inc.AmgenRecruitingNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, United Kingdom, Netherlands, Belgium
-
Verastem, Inc.Mirati Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Malignant Neoplasm of Lung | Malignant Neoplastic Disease | KRAS Activating MutationUnited States
-
Emory UniversityVerastem, Inc.Completed
-
University of OklahomaVerastem, Inc.RecruitingCervical Cancer | Solid Tumor | Endometrioid Cancer | Mucinous Ovarian Cancer | High Grade Serous Ovarian CancerUnited States
-
University of UtahVerastem, Inc.Recruiting
-
University of ChicagoVerastem, Inc.RecruitingColorectal Cancer | Colorectal Cancer Metastatic | Colorectal Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Colorectal AdenocarcinomaUnited States
-
Thomas Jefferson UniversityVerastem, Inc.Active, not recruitingMetastatic Uveal MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterVerastem, Inc.RecruitingLow-Grade Serous Ovarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterVerastem, Inc.Recruiting
-
Memorial Sloan Kettering Cancer CenterVerastem, Inc.RecruitingMesonephric Gynecologic CancerUnited States
-
Washington University School of MedicineVerastem, Inc.Completed
-
Institute of Cancer Research, United KingdomVerastem, Inc.Active, not recruitingPancreatic Cancer | NSCLC | Low Grade Serous Ovarian Cancer | Endometrioid CarcinomaUnited Kingdom
-
Kerastem Technologies, LLCCompletedAlopecia, AndrogeneticUnited States
-
Emory UniversityNational Cancer Institute (NCI); Verastem, Inc.RecruitingGlioblastoma | Recurrent GlioblastomaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Verastem, Inc.RecruitingPancreas Adenocarcinoma | Pancreas Cancer | Cancer of the PancreasUnited States
-
Michael McHaleVerastem, Inc.; Nine Girls AskRecruitingROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAKOvarian CancerUnited States
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingLow Grade Serous Ovarian CancerUnited States, United Kingdom, Australia
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian Cancer | Low Grade Ovarian Serous AdenocarcinomaSpain, United States, Belgium, United Kingdom, France, Canada, Italy
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Sorrento Therapeutics, Inc.VetStem Biopharma, Inc.; Fresno Community Hospital and Medical CenterCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Verastem, Inc.RecruitingPancreatic Ductal Adenocarcinoma | Resectable Pancreatic Ductal Adenocarcinoma (PDAC)United States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Verastem, Inc.; Chugai PharmaceuticalRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Solid TumoursUnited Kingdom
-
Washington University School of MedicineMerck Sharp & Dohme LLC; The Foundation for Barnes-Jewish Hospital; Verastem,...CompletedPancreatic Cancer | Advanced Solid Tumors | Solid TumorsUnited States
-
Oslo Metropolitan UniversityUniversity of Oslo; Det Glutenfrie VerkstedRecruiting
-
IND Diagnostic Inc.Unknown
-
NHS Greater Glasgow and ClydeMerck Sharp & Dohme LLC; Cancer Research UK; University of Southampton; Queen's... and other collaboratorsUnknownPancreatic Neoplasms | Mesothelioma | Carcinoma, Non-small-cell LungUnited Kingdom
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.; Oncoceutics, Inc.RecruitingMetastasis | Endometrial CancerUnited States
-
IC-IT Sciences Inc.UnknownSleep DisturbanceUnited States
-
NC Medial Research IncRecruiting
-
Zhengzhou Gensciences IncHaimen Gensciences lncCompleted
-
Zhengzhou Gensciences IncJiangsu Gensciences lnc.Completed
-
IGC Pharma LLCRecruitingAggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive OutburstUnited States, Canada, Puerto Rico
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.RecruitingDiffuse Large B-cell LymphomaUnited States